Premium
OUTCOME DETERMINANTS OF COMMERCIAL CAR‐T CELL THERAPY FOR LARGE B‐CELL LYMPHOMA: RESULTS OF THE GLA/DRST REAL WORLD ANALYSIS
Author(s) -
Dreger P.,
Martus P.,
Holtick U.,
Ayuk F.,
WagnerDrouet E. M.,
Wulf G.,
Marks R.,
Penack O.,
Koenecke C.,
von Bonin M.,
von Tresckow B.,
Stelljes M.,
Baldus C.,
Vucinic V.,
Mougiakakos D.,
Topp M.,
Wolff D.,
Schroers R.,
Schmitt M.,
Schmitt T.,
Lengerke C.,
Thomas S.,
Beelen D. W.,
Bethge W.
Publication year - 2021
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.186_2880
Subject(s) - medicine , multivariate analysis , transplantation , lymphoma , oncology , hematopoietic stem cell transplantation